abstract |
The present invention relates to an aqueous solution useful as a pharmaceutical composition for posaconazole for intravenous administration. The composition comprises a solubilizing agent, for example, a modified? -Cyclodextrin in an acidified solution, which may also contain a chelating agent such as EDTA (EDTA). In clinical trials, a selected composition of 200 mg posaconazole dose has been shown to achieve acceptable pharmacokinetic properties. |